Endogenous DNA Damage Leads to p53-Independent Deficits in Replicative Fitness in Fetal Murine Fancd2−/− Hematopoietic Stem and Progenitor Cells  by Yoon, Young me et al.
Stem Cell Reports
ArticleEndogenous DNA Damage Leads to p53-Independent Deficits in Replicative
Fitness in Fetal Murine Fancd2/ Hematopoietic Stem and Progenitor Cells
Young me Yoon,1,2,3 Kelsie J. Storm,1,2,3,5 Ashley N. Kamimae-Lanning,1,2,3,6 Natalya A. Goloviznina,1,2,3,7
and Peter Kurre1,2,3,4,*
1Department of Pediatrics
2Pape´ Family Pediatric Research Institute
3Pediatric Cancer Biology Program
Oregon Health & Science University, Portland, OR 97239, USA
4OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA
5Present address: Randall Children’s Hospital, Portland, OR 97227, USA
6Present address: MRC Laboratory of Molecular Biology, Protein & Nucleic Acids Division, Cambridge CB2 0QH, UK
7Present address: Molecular, Cellular, and Structural Biology, University of Minnesota, Minneapolis, MN 55455, USA
*Correspondence: kurrepe@ohsu.edu
http://dx.doi.org/10.1016/j.stemcr.2016.09.005SUMMARYOur mechanistic understanding of Fanconi anemia (FA) pathway function in hematopoietic stem and progenitor cells (HSPCs) owes
much to their role in experimentally induced DNA crosslink lesion repair. In bone marrow HSPCs, unresolved stress confers p53-depen-
dent apoptosis and progressive cell attrition. The role of FA proteins duringhematopoietic development, in the face of physiological repli-
cative demand, remains elusive. Here, we reveal a fetal HSPC pool in Fancd2/mice with compromised clonogenicity and repopulation.
Without experimental manipulation, fetal Fancd2/ HSPCs spontaneously accumulate DNA strand breaks and RAD51 foci, associated
with a broad transcriptional DNA-damage response, and constitutive activation of ATM as well as p38 stress kinase. Remarkably, the
unresolved stress during rapid HSPC pool expansion does not trigger p53 activation and apoptosis; rather, it constrains proliferation.
Collectively our studies point to a role for the FA pathway during hematopoietic development and provide a new model for studying
the physiological function of FA proteins.INTRODUCTION
Fanconi anemia (FA) is a recessively inherited, multisystem
disorder characterized by congenital anomalies, hemato-
poietic failure, and cancer predisposition (Kutler et al.,
2003). Biallelic mutations in one of at least 22 identified
FA genes (with the exception of X-linked FANCB) result
in progressive stem cell attrition in 90% of affected patients
(Kee and D’Andrea, 2012). Human andmurine FA hemato-
poietic stem and progenitor cells (HSPCs) exhibit charac-
teristic susceptibility to DNA-crosslinking agents (Knipsch-
eer et al., 2009) and chronic inflammatory stimulation (Hu
et al., 2013; Rathbun et al., 1997), as well as an exaggerated
sensitivity to aldehydes when canonical elimination path-
ways are disabled (Garaycoechea and Patel, 2014; Pontel
et al., 2015). Yet the physiological role of FA proteins in
maintaining HSPC pool size remains to be clarified, owing,
in part, to a lack of model systems that mimic the sponta-
neous and progressive hematopoietic failure seen in pa-
tients (Garaycoechea and Patel, 2014; Walter et al., 2015).
To gain insight into the role of FA proteins during devel-
opment and understand the origin of HSPC deficits, we
recently investigated fetal hematopoietic function in amu-
rine model of FA, observing quantitative hematopoietic
deficits at embryonic day 14.5 (E14.5) (Kamimae-Lanning
et al., 2013). This is consistent with a case report of
compromised cord blood clonogenicity and observations840 Stem Cell Reports j Vol. 7 j 840–853 j November 8, 2016 j ª 2016 The
This is an open access article under the CC BY-NC-ND license (http://creativof decreased bone marrow progenitor content in young
FA patients (Auerbach et al., 1990; Ceccaldi et al., 2012).
Indeed, rapid proliferation during experimental transplan-
tation of murine FA bone marrow, progenitor proliferation
in rapidly dividing FANCD2- and FANCA-depleted human
embryonic stem cells (Tulpule et al., 2010), or primordial
germ cell turnover (Luo et al., 2014) all reveal proliferation
deficits following replication stress. During development,
definitive murine HSPCs experience a rapid 33-fold expan-
sion in the fetal liver (FL) between E12.5 and E16.5 (Ema
and Nakauchi, 2000; Mikkola and Orkin, 2006), after
which hematopoietic function transitions to the bone
marrow where HSPCs assume a more quiescent postnatal
phenotype (Copley et al., 2013; Morrison and Spradling,
2008).
HSPCs have evolved complex regulatory systems tomini-
mize DNA damage accrued in response to endogenous and
exogenous compounds or associated with aging (Bakker
and Passegue, 2013; Flach et al., 2014; Lindahl, 1993).
The FA pathway appears to shift double-strand-break repair
away from the more error-prone non-homologous end-
joining (NHEJ) repair pathway (Kottemann and Smogor-
zewska, 2013; Zhang et al., 2016). Components of the alter-
native homologous combination (HR) pathway are critical
to progenitor repair integrity, suggesting that the disrup-
tion of the FA pathway would leave the progenitor pool
especially vulnerable to damage accrual (Mohrin et al.,Author(s).
ecommons.org/licenses/by-nc-nd/4.0/).
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2010). Recent studies further suggest that protective mech-
anisms are required to balance the physiological replicative
stress that coincides with rapid cell division during he-
matopoietic development (Alvarez et al., 2015; Copley
et al., 2013; Mikkola and Orkin, 2006).
Thus, fetal hematopoiesis provides a unique opportunity
to test the hypothesis that FA proteins have a physiological,
alkylator-independent role in guarding against replication
stress during development, preventing attrition in the
rapidly cycling fetal HSPC pool (Lossaint et al., 2013; Lueb-
ben et al., 2014). Our data from Fancd2/ FL HSPC herein
reveal deficits in proliferative fitness and a broad damage
response with constitutive activation of p38, but no
evidence of the characteristic postnatal p53 response or
apoptosis.RESULTS
Fancd2/ Fetuses Exhibit Pervasive Developmental
Defects and a Deficiency of Fetal Liver HSPCs
To investigate the prenatal role of the FA pathway,we chose
a model of Fancd2 deficiency, a critical component in the
coordination of downstream nuclear DNA repair events
(Grompe and D’Andrea, 2001; Zhang et al., 2010). FL
cells were obtained from wild-type (WT) and Fancd2-defi-
cient embryos from Fancd2+/ timed breeders at 12.5 and
14.5 days post coitum (dpc). We characterized FL HSPCs
at each time point by immunophenotypic analysis of ASL
(AA4.1+SCA1+Linlow/-) and SLAM (CD150+CD48Linneg
SCA1+) cells (Kiel et al., 2005; Kim et al., 2006; Yilmaz
et al., 2006). Fancd2/ fetuses were present at a sub-Men-
delian frequency at both time points, comprising 17.7%–
18.7% of the total fetuses (Figure 1A) but only 9% of wean-
lings (Q. Zhang, personal communication), indicating an
association with both early and late gestational lethality.
Notably, Fancd2/ fetuses often exhibited gross abnormal-
ities such asmicrocephaly andmicrophthalmia (Figure 1B).
At 12.5 dpc, Fancd2/ fetuses exhibited a 51% deficit in FL
mass alongwith a 27% decline in liver cellularity relative to
WT (Figures 1C and 1D). Not surprisingly, the overall num-Figure 1. Fancd2/ Fetal Mice Have a Significantly Diminished H
(A) Offspring yields of each genotype at 12.5 and 14.5 days post coi
(B) Common craniofacial defects seen in Fancd2/ fetal mice.
(C–F) Characterizations of WT and Fancd2/ fetal mice at 12.5 dpc: fe
HSPCs, and percentage of SLAM HSCs in live FL cells (n = 8 WT and 7
(G–J) Characterizations of WT and Fancd2/ fetal mice at 14.5 dpc:
cellularity (p = 0.001, n = 7 WT and 14 KO from five litters), percentag
percentage of SLAM HSCs in live FL cells (p = 0.01, n = 4 WT and 3 KO
(K) Cytokine profiling of ASL-sorted WT and Fancd2/ unfractionate
lower than the detection threshold are excluded, hence a statistical
Error bars reflect SEM, and asterisks indicate *p% 0.05, **p% 0.01
842 Stem Cell Reports j Vol. 7 j 840–853 j November 8, 2016ber of both ASL and SLAMHSPCs was reduced in Fancd2/
FL even as their respective frequencies remained compara-
ble with WT (Figures 1E and 1F). The underlying lack of
FL cell expansion is readily apparent at 14.5 dpc. The
Fancd2/ fetuses were 31% smaller (Figure 1C) and their
livers had 64% fewer cells than WT (Figure 1D), an even
more significant proportional deficit than at the earlier
time point. Strikingly, by 14.5 dpc the ASL and SLAM he-
matopoietic stem cell (HSC) frequencies were significantly
lower in Fancd2/ FL compared withWT, comprising 27%
and 61%, respectively (Figures 1I and 1J). Whereas adult
Fancc/ HSPC show an exaggerated susceptibility to
inflammation, a Luminex screening of key inflammatory
cytokines showed only modest increases in interleukin-6
(IL-6) and IL-4 release from Fancd2/ ASL FL at 14.5 dpc
(Figure 1K), generally consistent with FA patient immuno-
logical profiles (Korthof et al., 2013).Fancd2/ Fetal Liver HSPCs Are Irreversibly
Compromised and Exhibit Characteristic Sensitivity
to DNA-Crosslinking Agents
To assess the hematopoietic progenitor cell content in
Fancd2/ FL, we conducted methylcellulose colony-for-
mation assays from both Fancd2/ andWTunfractionated
FL, with and without the addition of a DNA interstrand
crosslinker, mitomycin C (MM-C). At 12.5 dpc, WT and
Fancd2/ FLs formed 77 and 72 colonies on average with
no statistical difference (Figure 2A). In the analyses with
FLs at 14.5 dpc, both WT and Fancd2/ FL formed fewer
colonies compared with the FLs at 12.5 dpc. Moreover,
Fancd2/ FL formed significantly fewer colonies than
WT, even in the absence of MM-C, consistent with the
notion that progenitor depletion occurs in this model
unprovoked by exposure to exogenous agents. These find-
ings were exacerbated with MM-C, which reduced output
from both WT and Fancd2/ FL, but more significantly
affected formation of Fancd2/ FL colonies (Figure 2B).
This phenotype persisted into adulthood (Figure 2C). We
next performed serial transplantation assays, injecting
unfractionated WT and Fancd2/ CD45.2 donor FL intoematopoietic Compartment and Fewer HSCs
tum (dpc) from Fancd2+/ 3 Fancd2+/ crosses.
tus weight (p = 0.01), liver cellularity (p < 0.001), percentage of ASL
knockout [KO] from four litters).
fetus weight (p = 0.04, n = 7 WT and 8 KO from five litters), liver
e of ASL HSPCs (p = 0.03, n = 10 WT and 11 KO from five litters), and
from two2 litters).
d FL cells (n = 3 WT and 5 KO from two litters; samples that yielded
test could not be performed).
, and ***p% 0.001. n.s., not significant.
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
WT Fancd2-/- 
C
FU
/2
0,
00
0 
ce
lls
 a
t 1
2.
5 
dp
c
n.s. 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
!" !#$" %" %#$" &" &#$" '"
%
 D
on
or
 c
hi
m
er
is
m
  
WT d2-/-         WT d2-/- 
   4 weeks          16 weeks 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
0 0.5 1 1.5 2 2.5 3 WT d2-/-    WT d2-/-    4 weeks          14 weeks 
*
E
A
*** ***
*** ***H
0 
10 
20 
30 
40 
50 
60 
0 10 100 50 
C
FU
/2
0,
00
0 
ce
lls
 a
t 1
4.
5 
dp
c 
Mitomycin-C (nM) 
WT FL
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
0 10 100 1000 
C
FU
/2
0,
00
0 
ce
lls
 
Mitomycin-C (nM) 
WT BM
*
* * *
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
!" !#$" %" %#$" &" &#$" '"
%
 D
on
or
 c
hi
m
er
is
m
 in
 s
ec
on
da
ry
 
WT d2-/-        WT d2-/-
4 weeks          14 weeks 
Fancd2-/- FL Fancd2-/- BM
%
 D
on
or
 c
hi
m
er
is
m
 in
 p
rim
ar
y
CB
FD CD45.2 WT or Fancd2-/- FL
CD45.1 WT secondary recipient
8 x 105  cells
CD45.1 WT
primary recipient
8 x 105 cells
CD45.1 WT or 
Fancd2-/- BM
CD45.1 WT recipient
1 x 106  cells
G
Figure 2. Defects in Fancd2/ HSPC Frequency and Repopulating Capacity Persist from Fetal Development through Adulthood
(A) Colony-forming units per 20,000 unfractionated FL cells at 12.5 dpc (n = 5 WT and 3 KO from two litters).
(B) Colony-forming units per 20,000 unfractionated FL cells at 14.5 dpc with different doses of mitomycin C treatment (p < 0.05 between
WT and Fancd2/ at each concentration of MM-C, n = 5–6 WT per condition and 4–6 KO per condition from five litters).
(C) Colony-forming units per 20,000 adult whole bone marrow cells (n = 2 WT and 4 KO).
(legend continued on next page)
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congenic CD45.1, sublethally irradiated recipients (Fig-
ure 2D). Primary recipients of Fancd2/ FL cells exhibited
a 22% decrease in peripheral blood donor chimerism at
4 weeks and a 10% decrease in peripheral blood donor
chimerism at 14 weeks, compared with WT (Figure 2E).
This proliferation deficit was further aggravated by a sec-
ond round of transplantation using unfractionated bone
marrow from primary transplant recipients, revealing a
73% decrease in peripheral blood donor chimerism at
4 weeks from Fancd2/ grafts, which persisted through
14 weeks, in comparison with WT (Figure 2F). Similarly,
HSPC-repopulating defects in adult bone marrow can be
uncovered with the stress of transplantation, prompting a
significant decrease of 42% in Fancd2/ peripheral blood
donor chimerism at 4 weeks and 45% at 16 weeks,
compared with WT donor bone marrow (Figures 2G and
2H). Taken together, our results demonstrate a pervasive
developmental defect in Fancd2-deficient mice, with a
constitutive loss of proliferative capacity and HSC self-
renewal that coincides with physiological replication stress
during developmental expansion in the FL.
Fancd2/ FL HSPCs Show Activated DNA-Damage
Responses and Accumulation of DNA Strand Breaks
Hypothesizing that the DNA replication stress during rapid
cell division in FL HSPCs requires FA pathway integrity, we
investigated whether DNA-damage response (DDR) ele-
ments were activated in Fancd2/ FL at 14.5 dpc. We as-
sessed the presence of spontaneous double-strand breaks
by conducting immunofluorescent labeling of gH2AX in
SCA1-enriched FL HSPCs. Although Fancd2/ FL HSPCs
showed a modest increase in the percentage of cells pre-
sentingmore than five gH2AX foci, no statistical difference
between WT and Fancd2/ FL HSPCs was observed at
lower levels of damage (Figures 3A and 3B). As a validated
alternative, we then sought evidence of DNA repair activa-
tion by investigating the presence of nuclear RAD51, a pro-
tein that binds single-stranded DNA to facilitate homolo-
gous strand searching (Lundin et al., 2003), and observed
a significant increase in the percentage of HSPCs with
RAD51 foci in Fancd2/ FL, compared with WT (Figures
3C and 3D). Next, we assayed the relative expression
of DDR genes in Fancd2/ and WT FL HSPC. Among
SCA1+ FL cells, we found a consistent trend for transcrip-(D) Schema for FL transplantation into primary and secondary recip
recipients (donor n = 2 WT and 4 KO FLs from two litters). In the subseq
recipients were injected into three recipients per donor.
(E) CD45.2 chimerism in peripheral blood of primary recipients at 4 w
(F) CD45.2 chimerism in peripheral blood of secondary recipients at 4
(G) Transplantation schema for adult bone marrow cells. Each donor
(H) CD45.2 chimerism in peripheral blood (p < 0.001 at both time po
Error bars reflect SEM, and asterisks indicate *p% 0.05, **p% 0.01
844 Stem Cell Reports j Vol. 7 j 840–853 j November 8, 2016tional upregulation of genes involved in both HR and
NHEJ, including Rad51, Xrcc5, Xrcc6, Xrcc2, and Prkdc, in
Fancd2/, although only Prkdc was statistically significant
(Figure 3E). In an additional survey of Rad51, Xrcc2, and
Prkdc transcripts in the more highly enriched ASL HSPC
population, we found that Xrcc2 was significantly upregu-
lated, with Rad51 expression trending upward in Fancd2-
deficient cells (Figure 3F). Finally, we sought to corroborate
DNA damage in Fancc/ and Fancd2/ FL HSPCs via the
alkaline comet assay, a measure of single- or double-strand
breaks (Beerman et al., 2014). Analysis of SCA1-enriched FL
HSPCs showed a significant increase in strand breaks in
both Fancc/ and Fancd2/ FL compared with WT (Fig-
ures 3G–3I). Importantly, cells assayed were not subjected
to exogenous stress via interstrand crosslinker exposure.
Thus, the aggregate results demonstrate a broad DDR in
response to fetal hematopoietic replicative demand in the
context of FA pathway deficiency.
Fancd2/ FL HSPCs Exhibit Constitutive Activation
of p53-Independent Downstream Stress Responders
Adult FA HSPCs undergo apoptosis and exhibit a canonical
p53 response elicited by exogenous cell stress (Ceccaldi
et al., 2012). Similarly, under exogenous induction such
as irradiation, p53 is phosphorylated in both WT and
Fancd2/ SCA1+ FL cells (Figure 4A). However, in our an-
alyses of total and phosphorylated (Ser15) p53 expression
in unperturbed fetal HSPCs, by western blot and phospho-
flow cytometry, respectively, we found nomajor difference
between WT and Fancd2/ FL cells (Figures 4B–4E).
Consistent with this apparent lack of p53 response, we
found no evidence of apoptosis in Fancd2/ HSPCs
when we analyzed annexin V staining by flow cytometry
and expression of pro-apoptotic p53 target genes, Puma
and Noxa (Figures 4F and 4G). During the cell-cycle anal-
ysis using Ki-67 and Hoechst staining (Figure 4H), we
observed the rapid cell-cycling characteristics of FL with
90% of KSL cells out of the quiescent state. However,
there was neither checkpoint arrest nor a significant
difference in the proportion of cells in each cell-cycle
state between WT and Fancd2/ (Figure 4I). To further
delineate the canonical stress response, we next studied
the expression of phosphorylated ataxia telangiectasia
mutated (ATM), an upstream kinase of DDR and cell-cycleients. For the primary, each FL donor was transplanted into three
uent transplantation, bone marrow from two WT to three KO primary
eeks (p = 0.02) and 14 weeks (p = 0.006) post transplant.
weeks (p < 0.001) and 14 weeks (p = 0.02) post transplant.
was transplanted into five recipients (donor n = 2 WT and 2 KO).
ints).
, and ***p% 0.001.
A B
C D
E F
G H I
Figure 3. DNA-Damage Responses Are
Induced, and the Strand Breaks Are Accu-
mulated in FA FL HSPCs
(A) Representative gH2AX foci in SCA1+ FL
cells (603 objective lens; the scale bar rep-
resents 5 mm).
(B) Quantification of gH2AX foci per cell
(n = 3 WT and 3 KO from three litters).
(C) Representative RAD51 foci in SCA1+ FL
(603 objective lens; the scale bar represents
5 mm).
(D) Quantification of cells positive for foci
(p = 0.02, n = 6 WT and 6 KO from three
litters).
(E) Expression of DDR genes in SCA1+ FL cells
(p = 0.08, 0.44, 0.06, 0.22, and 0.005,
respectively; n = 4 WT and 4 KO from three
litters).
(F) Expression of selected DDR genes in ASL-
sorted FL cells (p = 0.08, 0.5, 0.04 respec-
tively; n = 3 WT and 3 KO from two litters).
(G) Olive tail moment of 428 SCA1+ FL cells
from seven WT animals and 288 SCA1+ FL cells
from five Fancc/ animals from four litters
(p = 0.003).
(H) Olive tail moment of 289 SCA1+ FL cells
from five WT animals and 267 SCA1+ FL cells
from five Fancd2/ animals from four litters
(p = 0.04).
(I) Representative alkaline comets of SCA1+
FL cells (203 objective lens; the scale bar
represents 20 mm).
Error bars reflect SEM, and asterisks indicate
*p% 0.05 and **p% 0.01.checkpoint (Burma et al., 2001; Ito et al., 2004), by intra-
cellular flow cytometry. In every set of litters we investi-
gated, phospho-ATM was significantly upregulated in
Fancd2/ FL compared with WT FL by 24% on average
(Figures 4J and 4K). Collectively, our findings elucidate
a model of compromised proliferation in Fancd2/ FL
HSPC without p53-mediated cell-cycle arrest or apoptosis
in response to replication stress.Fancd2/ FLProgenitor andRepopulatingDefects Are
Partially Reversed by p38 MAPK Inhibition
Because the experimental induction of cell stress in FA he-
matopoietic cells prompts expression of p38 mitogen-acti-
vated protein kinase (MAPK), which senses DNA damage
and maintains HSPC proliferation and self-renewal (Ito
et al., 2004; Saadatzadeh et al., 2009; Svahn et al., 2015),
we asked whether Fancd2/ FL HSPCs also show increasedStem Cell Reports j Vol. 7 j 840–853 j November 8, 2016 845
p38 MAPK activation during rapid FL expansion. Here, we
used intracellular flow cytometry and immunofluorescence
assays (Figures 5A and 5B) and found significant constitu-
tive activation of p38 MAPK in Fancd2/ FL compared
with WT FL from both methods (Figures 5C and 5D). We
then sought to determine whether p38 MAPK inhibition
would rescue proliferation in Fancd2/ FL HSPCs. First,
we investigatedhematopoietic outputvia colony formation
in methylcellulose, with and without the addition of the
p38MAPK inhibitors SB203580andLY2228820.Co-culture
with 10 mMSB203580 and100nMLY2228820 significantly
increased colony formation from Fancd2/ FL progenitors
by 120%, eliminating the difference in colony formation
between WT and Fancd2/ (Figure 5E). Next, we cultured
unfractionated Fancd2/ and WT FL cells overnight with
10mMSB203580orDMSOvehicle control and transplanted
them into sublethally irradiated congenic recipient
mice. Subsequently, we injected mice with SB203580 or
DMSO intraperitoneally, three times weekly, as previously
described (Ito et al., 2006) (Figure 5F). Strikingly, in vivo in-
hibition of p38MAPK significantly improved the repopula-
tionof Fancd2/ FL at theweek 4 timepoint,when engraft-
ment was on a par with WT control recipients (Figure 5G).
At a later time point (week 11), donor chimerism remained
similar to that of the early time point. However, statistical
significance was lost due to animal deaths potentially
caused by the susceptibility of Fancd2/ FL recipients to
the toxicity of DMSO (Figure 5F). Altogether, our data
demonstrate activation of a canonical cell stress pathway
in Fancd2/ FL that is amenable topharmacological rescue.DISCUSSION
HSPC function under stress conditions is severely compro-
mised in models with experimentally disabled DDR (Beer-
man et al., 2014), and our data indicate that DNA repair
integrity via the FA pathway is required for proper HSPC
pool expansion during development. Mechanistically,
HSPC depletion in the FL differs from progressive postnatal
losses after exposure to exogenous alkylating agents, alde-
hyde metabolites, or innate immunostimulation (Garay-
coechea and Patel, 2014; Hu et al., 2013; Kutler et al.,
2003; Pontel et al., 2015; Walter et al., 2015). Accordingly,
the moderately severe spontaneous hematopoietic defects
observed in Fancd2 adult mice (Parmar et al., 2010; Zhang
et al., 2010) and in FA patients would represent postnatal
progression of hematopoietic failure rather than a de
novo onset (Auerbach et al., 1990; Ceccaldi et al., 2012).
During hematopoietic development in the FL, rapidly
cycling HSPCs experience significant replicative stress
(Fleming et al., 1993; Mikkola and Orkin, 2006; Morrison
et al., 1995; Morrison and Spradling, 2008). DNA repair846 Stem Cell Reports j Vol. 7 j 840–853 j November 8, 2016integrity is crucial in mitigating replication stress during
HSPC pool expansion and maintenance of genome stabil-
ity (Alvarez et al., 2015; Bakker and Passegue, 2013; Beer-
man et al., 2014; Zhang et al., 2011). Our data comparing
phenotypes and progenitor frequency of FL HSPCs be-
tween 12.5 and 14.5 dpc provide evidence that Fancd2-defi-
cient HSPCs fail to adequately expand in the fetal liver,
coincident with DNA-damage accumulation and elevated
stress response observed at 14.5 dpc. Equivalent ASL and
SLAM frequencies, as well as the colony formation by WT
and Fancd2/ HSPCs at 12.5 dpc, indeed suggest that
the significant hematopoietic attrition occurs during FL
expansion, a narrow time period of heightened replicative
demand. At 14.5 dpc, we confirm significant SLAM-HSC
deficits and dramatically diminished proliferative capacity
during Fancd2 deficiency, thereby setting the stage for post-
natal Fancd2/ bone marrow HSPC compromise.
The ensuing replication stress during rapid expansion
elicits a broad DDR, when Fancd2/-deficient HSPC accu-
mulate DNA damage and activate p38MAPK in response to
physiological replication demands encountered during
development. The lack of a more robust gH2AX phosphor-
ylation seemed initially surprising to us, but has been re-
ported before (Burma et al., 2001; Ciccia and Elledge,
2010; Zha et al., 2008). However, a significant accumula-
tion of DNA strand breaks, as well as RAD51 foci, along
with the transcriptional elevation of repair genes in the
ASL-sorted population clearly indicate the overall activa-
tion of DDR in Fancd2/ HSPCs (Beerman et al., 2014;
Mohrin et al., 2010; Zhang et al., 2016). Not surprisingly,
the magnitude of DDR was comparatively more modest
in Fancd2/ FL HSPCs than that observed after typical
interstrand crosslinker exposure or chronic injury models
(Hu et al., 2013; Walter et al., 2015). This is entirely consis-
tent with an operational model of diminished, but not
eliminated in utero HSPC function, and experimentally
supported by fetal deficits in Fancd2/ that are not due
to apoptosis but rather result from diminished proliferative
capacity (Alvarez et al., 2015; Shen et al., 2013; Zhang et al.,
2011). Our observations are further consistent with sponta-
neous developmental deficits that arise during rapid
mitotic cycles in Fancc and Fancm germ cell proliferation
(Luo et al., 2014; Nadler and Braun, 2000).
Fetal HSPCs display unique molecular and functional
properties before they transition postnatally to the defini-
tive adult phenotype (Bowie et al., 2007). Although p53
is readily phosphorylated by irradiation in both WT and
Fancd2/ FLHSPCs and active during development in gen-
eral (reviewed in Molchadsky et al., 2010), our studies
reveal that fetal FAHSPCDDRs are independent of p53 acti-
vation. This finding diverges from a well-described pheno-
type in adult FA models (Ceccaldi et al., 2012; Garaycoe-
chea and Patel, 2014; Zhang et al., 2013). A recent study
A B C
D E F G
H I
J K
Figure 4. FA Fetal HSPC Attrition Is Not Associated with p53-Mediated Apoptosis or Cell-Cycle Arrest
(A) Representative histogram showing the activation of phospho-p53 (ser15) after 5 Gy irradiation in WT and Fancd2/ FL, respectively,
compared with the non-irradiated controls.
(B) Immunoblots for p53 and GAPDH from whole FL lysates (bands are representative of multiple experiments, n = 3).
(C) Densitometry of p53 protein bands from Fancd2/ whole FL compared with WT, normalized to GAPDH (p = 0.78, n = 7 WT and 4 KO from
3 litters).
(D) Representative histogram showing the intracellular staining of phospho-p53 (ser15) in WT and Fancd2/ SCA1+ FL cells.
(E) Expression of phospho-p53 (ser15) in WT and Fancd2/ SCA1+ FL cells as the mean frequency of intensity (p = 0.16, n = 5 WT and 3 KO
from two litters).
(F) Percentage of ASL cells positive for annexin V (p = 0.75, n = 5 WT and 5 KO from two litters).
(legend continued on next page)
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shows that the p53 response is indeed linearly correlated
with the number of DNA breaks (Loewer et al., 2013).
Hence, it is conceivable FL HSPCs at 14.5 dpc may not
have accumulated enoughDNA damage to reach threshold
p53 activity to induce apoptosis or cell-cycle arrest. The
data consistently show that Fancd2/ FL cells encounter
genomic stress that activates DDR elements during replica-
tion, not seen in adult HSPCs (Fleming et al., 1993). Similar
to a previous report on HSPC development (Nygren et al.,
2006), we find no accumulation in G0, G1, or S-G2-M cell-
cycle phase, suggesting that cell-cycle transit is evenly
prolonged, whereby ATM activation is insufficient to acti-
vate checkpoints, leaving cell-cycle phase distribution un-
changed, even as Fancd2/ proliferation and repopulation
decline.
Others showed that constitutive activation of the p38
MAPK ‘‘stress kinase’’ results in HSPC pool depletion (Bak-
ker and Passegue, 2013; Ito et al., 2006). Our studies herein
not only corroborate activation of p38 MAPK in Fancd2/
FL cells, but demonstrate rescue of the proliferative capac-
ity after pharmacological p38 MAPK inhibition both
in vitro and in vivo (Ito et al., 2004, 2006). Although our
in vivo treatment with SB203580 in Fancd2/ FL recipi-
ents precluded full evaluation of the long-term effect on
HSCs, rescue strategies involving short-term p38 MAPK in-
hibition or using a more potent and less toxic compound,
such as LY2228820 (Campbell et al., 2014), might provide
a more definitive answer. Yet while several reports and our
data imply that p38 MAPK could be a potential therapeu-
tic target to ameliorate hematopoietic failure in FA pa-
tients, it is important to consider that this leaves HSPCs
vulnerable to DNA-damage accumulation and genomic
instability (Anur et al., 2012; Briot et al., 2008; Garbati
et al., 2013; Pearl-Yafe et al., 2004; Saadatzadeh et al.,
2009).
Taken together, we demonstrate that Fancd2/ mice
exhibit a pervasive developmental HSPC defect that echoes
the constitutional defects evident at birth in a subset of
FA patients. Mechanistically, the data support a model
whereby the physiological replication stress in rapidly
cycling Fancd2/ fetal HSPCs spontaneously elicits DNA
damage and promotes the activation of p38 MAPK, result-
ing a diminished proliferative fitness, but without the char-
acteristic postnatal p53-mediated apoptotic response.(G) Expression of Puma and Noxa in WT and Fancd2/ ASL FL cells by
from two litters).
(H) Representative histogram and dot plot demonstrating Hoechst an
(I) Comparison between WT and Fancd2/ FL KSL cells in G0, G1, and
(J) Representative histogram showing the intracellular staining of ph
(K) Expression of phospho-ATM (Ser1981) in WT and Fancd2/ KSL FL
by the litter for t test; n = 2 WT, 1 KO in litter 1; n = 3 WT, 1 KO in li
Error bars reflect SEM and asterisks indicate *p% 0.05. N.S., not sig
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Mice
Mice were handled in accordance with OHSU IACUC guidelines.
FLs were harvested at 12.5 and 14.5 dpc during timed pregnancies
(vaginal plug method) from C57BL/6 Fancd2+/ dams (Houghtal-
ing et al., 2003). Fetal tissues were genotyped using the Phire
PCR Kit (Thermo Scientific). Bonemarrow cells from adult animals
were harvested as previously described (Skinner et al., 2008).
CFU-c
Methylcellulose progenitor assays (Mouse Methylcellulose Com-
plete Media, R&D Systems) were performed according to the man-
ufacturer’s instructions with unfractionated FL cells plated at
a concentration of 20,000 cells/mL. Assays with p38MAPK inhibi-
tion were conducted with 10 mMSB203580 (Calbiochem), 100 nM
LY2228820 (Selleckchem), or DMSO vehicle control.
Transplantation
Fetal liver transplants were performed with unfractionated FL cells
(8 3 105) by tail-vein injection into sublethally irradiated (750
cGy) congenic CD45.1 recipients. Transplantation assays with
in vivo p38MAPK inhibition were conducted after overnight incu-
bation of unfractionated FL cells with either 10 mM SB203580 (Cal-
biochem) or DMSO vehicle control; cells were then washed and in-
jected into irradiated recipients. Recipients received either 15mg/kg
SB203580 or DMSO via intraperitoneal injection three times per
weekaspreviouslydescribed(Itoet al., 2006). For adultbonemarrow
transplants,13106wholebonemarrowcellswere transplanted into
irradiated (750 cGy) CD45.1 recipients. Chimerism analysis was as
previously described (Skinner et al., 2008).
Flow Cytometry
For the KSL, ASL, and SLAM HSPC analyses, single-cell suspended
2–4 3 106 whole FL cells were washed in fluorescence-activated
cell sorting (FACS) buffer (Dulbecco’s PBS, 2% fetal bovine serum
[FBS]) and stained using LIVE/DEAD Fixable Green (Thermo Scien-
tific L23101), cKIT (BioLegend 105819), SCA1 (eBioscience 25-
5981-81),AA4.1/CD93 (eBioscience17-5892-82),CD48 (BioLegend
103422), and CD150 (BioLegend 115925) antibodies, as well as the
lineage antibodies: B220 (BD 553090), GR1 (BioLegend 108408),
CD3 (BD 555275), CD4 (BD 553653), CD5 (BD 553023), and
TER119 (BD 553673) at the manufacturers’ recommended concen-
trations (excludingMAC1 inFLanalyses [Morrisonet al., 1995]). For
the cell-cycle analysis, cells were stained for the populations above
as well as 20 mL fluorescein isothiocyanate anti-Ki-67 or anti-mouse
immunoglobulin G1 (IgG1) (BD 556026) and 0.1 mg/ml Hoechstreal-time qPCR (p = 0.02 and 0.16, respectively; n = 3 WT and 3 KO
d Ki-67 staining for the cell-cycle analysis of Fancd2/ KSL FL.
G2-M-S phases of the cell cycle (n = 11 WT, 8 KO from four litters).
ospho-ATM (Ser1981) in WT and Fancd2/ KSL FL cells.
cells as the mean frequency of intensity (p = 0.03, data were paired
tter 2; n = 1 WT, 2 KO in litter 3).
nificant.
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Figure 5. Inhibiting Constitutively Activated p38 MAPK Increases Clonogenicity in Fancd2/ FL
(A) Representative histogram showing the intracellular staining of phospho-p38 MAPK (T180/Y182) in WT and Fancd2/ KSL FL
cells.
(B) Expression of phospho-p38 MAPK (T180/Y182) in WT and Fancd2/ KSL FL cells as the mean frequency of intensity (p = 0.03, n = 4 WT
and 4 KO from two litters).
(C) Representative images showing the immunofluorescence staining of phospho-p38 MAPK (T180/Y182) in WT and Fancd2/ SCA1+ FL
cells (603 objective lens; the scale bar represents 5 mm).
(D) Immunofluorescence intensity of phospho-p38 MAPK (T180/Y182) in WT and Fancd2/ SCA1+ FL cells (p = 0.003, n = 5 WT and 4 KO
from three litters).
(E) WT and Fancd2/ colony-forming hematopoietic progenitor cell frequency with and without p38 MAPK inhibitors, 10 mM SB203580,
and 100 nM LY2228820 (p% 0.001 between WT and Fancd2/ at baseline with DMSO, p% 0.001 between Fancd2/ baseline and both
inhibitor conditions, n = 4–10 FL per condition from nine litters).
(F) Schema for transplantation of FL cells and p38 MAPK inhibitor treatment.
(legend continued on next page)
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(Thermo Scientific 62249). For annexin V staining, cells were
stained for ASL, 5 mL annexin V (BioLegend 640906), and 1 mg/mL
propidium iodide (Molecular Probes P3566) in ANNEXIN binding
buffer (10 mM HEPES, 140 mM NaCl, and 2.5 mM CaCl2
[pH 7.4]). For intracellular staining, KSL stained cells were fixed
with 2% paraformaldehyde (PFA), permeabilized with 0.5%
saponin, and stained using 0.2 mg PE anti-phospho-ATM (Ser1981)
(BioLegend 651203) and 0.2 mg PE rat anti-mouse IgG (BioLegend
406607), or 0.125 mg APC anti-phospho-p38 MAPK (T180/Y182)
(eBioscience 17-9078-42) and 0.5 mg APC goat anti-mouse IgG2
(BD 340473), or 1 mg anti-phospho-p53 (Ser15) (Cell Signaling
12571) and 1 mg PE rat anti-rabbit IgG (eBioscience 12-4739-81).
Data were collected on a BD FACSCalibur, Canto II, LSR II, or InFlux
(BD Biosciences), and analyzed by FlowJo software (TreeStar), using
unstained FL cells as the negative controls for gating and anti-IgG-
stained cells to normalize the mean fluorescence intensity.
Real-Time qPCR
KSL bone marrow or ASL FL cells were sorted by FACS on BD
InFlux. SCA1+ cells were isolated from bone marrow and FL using
theMouse PE SelectionKit (STEMCELLTechnologies) with PE anti-
SCA1 (BD 553336), and placed in Qiazol. Total RNA was purified
with the miRNeasy Mini Kit (Qiagen). mRNA was converted to
cDNA using SuperScript III First Strand (Invitrogen). Real-time
qPCR was performed on StepOne Plus using Power SYBR Green
Master Mix (Applied Biosystems). Primer sequences are described
in Table S1. Fancd2/ andWTsamples were normalized to b-actin,
and Fancd2/ gene expression was compared with WT.
Immunofluorescence
Single-cell suspensionsof FLwere enrichedby immunomagnetic se-
lection for SCA1, as for real-time qPCR. Enriched FL HSPCs were
fixed in 2% PFA and cytospun onto slides. Cells were permeabilized
with NET buffer with 0.5% Triton X-100 (Enns et al., 2012) and
stained with Hoechst (Thermo Scientific 62249) and AF488-conju-
gated anti-gH2AX (BioLegend, 613407), rabbit anti-mouse RAD51
(Santa Cruz Biotechnology, 8349) followed by Cy3 goat anti-rabbit
IgG (Millipore, AP132C) or Cy5-conjugated anti-phospho-p38
(T180/Y182) (eBioscience, 17-9078-42). For gH2AX and RAD51
immunofluorescence, cells were imaged using the Zeiss ApoTome
system and images were processed with Zen software (Zeiss). For
phospho-p38 immunofluorescence, z-stack images were acquired
using the DeltaVision Applied Precision System (GE Healthcare),
and the fluorescence intensity of cy5 within the nucleus area of
each cell was analyzed with Imaris software (Bitplane).
Comet Assay
FL cells were immunomagnetically enriched for SCA1 and then
prepared for alkaline comet assay as previously described (Olive
and Banath, 2006). Agarose-embedded cells were lysed in alkaline(G) CD45.2 chimerism in peripheral blood of FL recipients with or w
one-tailed t test between DMSO- and SB-treated Fancd2/ recipient
(H) CD45.2 chimerism in peripheral blood of FL recipients with or wit
DMSO, 4 WT + SB 5 KO + DMSO, 4 KO + SB).
Error bars reflect SEM, and asterisks indicate *p% 0.05 and ***p%
850 Stem Cell Reports j Vol. 7 j 840–853 j November 8, 2016conditions overnight at 4C followed by electrophoresis. Slides
were stained with 2.5 mg/mL propidium iodide, imaged on a Zeiss
Axioskop 2 Plus microscope, and analyzed with CaspLab software
(Konca et al., 2003).
Western Blot
FL cells were lysed using RIPA buffer with protease and phospha-
tase inhibitor cocktail (Thermo Scientific), followed by ultrasonica-
tion (Cole Parmer CPX-130). Lysates were prepared in LDS sample
buffer (Life Technologies) with 10% b-mercaptoethanol and boiled
for 5 min for denaturation. Denatured protein lysates were loaded
on 4%–15% Tris-HCl PAGE gel (Bio-Rad) for gel electrophoresis
separation (50 min at 200 V) and transfer (overnight at 25 V).
Transferred membranes were blocked with 5% non-fat dry milk
(Carnation, Nestle´) in Tris-buffered saline with Tween 20 and
blotted with anti-GAPDH (1:5,000, Novus Biologicals) and anti-
p53 (1:500, Santa Cruz), followed by anti-mouse and anti-rabbit
IgG horseradish peroxidase conjugates (Promega). Blots were
developed on X-ray film after 5-min exposure to the SuperSignal
West Pico Chemiluminescent HRP substrate (Thermo Scientific).
For quantification, protein band intensities were analyzed using
Image Studio Lite 5.2 (LI-COR).
Luminex Cytokine Profiling
FACS-sorted ASL FL cells were cultured in a 96-well plate in HSC
medium (Iscove’s modified Dulbecco’s medium, 15% FBS, 1%
penicillin-streptomycin) for 24 hr, and the supernatants were
analyzed for cytokines using a mouse Th1/Th2 Luminex panel
(eBioscience) which included IL-12, granulocyte macrophage col-
ony-stimulating macrophage (GM-CSF), interferon-g (IFN-g), IL-
1b, IL-13, IL-18, IL-2, IL-4, IL-5, IL-6, and tumor necrosis factor a
(TNF-a). This analysis was performed by the Endocrine Technolo-
gies Support Core at the Oregon National Primate Research Center
using the manufacturer’s instructions. In brief, 25 mL cell-culture
supernatant was incubated overnight with antibody-coated, fluo-
rescent-dyed capture microspheres specific for each analyte, fol-
lowed by detection antibodies and streptavidin-phycoerythrin.
Washed microspheres with bound analytes were resuspended in
reading buffer and analyzed on a Milliplex Analyzer (EMD Milli-
pore) bead sorter with XPonent Software version 3.1 (Luminex).
Data were calculated using Milliplex Analyst software version
5.1 (EMD Millipore). Intra-assay coefficients of variation were as
follows: IL-1b, 14.2%; IL-2, 10.4%; IL-4, 6.9%; IL-5, 18.1%; IL-6,
5.7%; IL-13, 7.2%; IFN-g, 25.4%; IL-12, 14.0%; GM-CSF, 24.5%;
TNF-a, 3.8%; IL-18, 6.4%. Because all samples were analyzed in a
single assay, no inter-assay variation was calculated.
Statistical Analysis
All numerical results shown are expressed as mean ± SEM. Two-
tailed Student’s t tests were performed for statistical analyses,ithout SB203580 treatment at 4 weeks post transplant (p = 0.03,
s; n = 4 WT + DMSO, 4 WT + SB, 11 KO + DMSO, 10 KO + SB).
hout SB203580 treatment at 11 weeks post transplant (n = 3 WT +
0.001. N.S., not significant.
unless otherwise stated in the figure legends. A p value of less than
or equal to 0.05 was considered significant.SUPPLEMENTAL INFORMATION
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